
An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Jeff L. Garwin, PhD, MD, is associate clinical science director, Strategic Development Consulting, at PPD, part of Thermo Fisher Scientific.

An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.

An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.

August 2nd 2023

August 2nd 2023